Status:
COMPLETED
Online MBCT vs HEP for Depressive Symptoms in Older Adults: RCT
Lead Sponsor:
Lady Davis Institute
Collaborating Sponsors:
Douglas Mental Health University Institute
Conditions:
Older Age; Depression
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
In Canada, depression affects more than 300,000 adults over the age of 60, which costs the healthcare system an estimated $5 billion each year. Late-life depression (LLD) is associated with more death...
Detailed Description
Depression in older adults is associated with increased mortality, physical comorbidity, and neurocognitive decline. Up to 50-80% of patients are resistant to pharmacotherapy. Although psychotherapies...
Eligibility Criteria
Inclusion
- Ability to provide informed consent (shown as to be able to explain back to the research assistant the purpose of the study as well as voluntary participation, rights, time commitments, etc.)
- MADRS score ≥ 10 (experiencing symptoms of moderate/severe depression) at baseline.
- Participants who have access to internet and basic digital skills to use their computer/tablet. -- Willing and able to attend ≥75% of MBCT or HEP sessions.
- Adequate understanding of English or French.
- Ability to sit for 90 minutes without discomfort.
- Willing to inform if any change is made to their psychotropic medications and dosage for the first 8 weeks of the study
Exclusion
- cognitive deficits at baseline, as defined by T-MoCA score \<19.
- diagnosis of post-traumatic stress disorder, bipolar I or II disorder, primary psychotic disorder (e.g. schizophrenia, schizoaffective disorder), and/or severe personality disorder interfering with ability to function in a group setting intervention on a regular basis.
- substance abuse within the past 6 months.
- high suicide risk (e.g., active suicidal ideation and/or recent intent or plan).
- significant visual or hearing impairment
- significant impairments in fine motor skills.
- any medical illnesses that could prevent the participant from engaging in the intervention.
- history of psychiatric hospitalization in the last 3 months
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06189118
Start Date
September 1 2023
End Date
February 2 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Verdun, Quebec, Canada, H4H 1R3